Xponance Inc. Has $5.17 Million Stock Holdings in AMETEK, Inc. (NYSE:AME)
Xponance Inc. lessened its stake in shares of AMETEK, Inc. (NYSE:AME – Free Report) by 1.1% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 31,033 shares of the technology company’s stock after selling 359 shares during the period. Xponanc…
Xponance Inc. Has $5.17 Million Stock Holdings in AMETEK, Inc. (NYSE:AME)
Xponance Inc. lessened its stake in shares of AMETEK, Inc. (NYSE:AME – Free Report) by 1.1% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 31,033 shares of the technology company’s stock after selling 359 shares during the period. Xponance Inc.’s holdings in AMETEK were worth $5,174,000 as of its most recent SEC filing.
Several other large investors have also recently bought and sold shares of AME. D.A. Davidson & CO. acquired a new stake in shares of AMETEK in the 4th quarter valued at approximately $201,000. Cambridge Investment Research Advisors Inc. lifted its stake in AMETEK by 238.4% in the fourth quarter. Cambridge Investment Research Advisors Inc. now owns 14,537 shares of the technology company’s stock valued at $2,397,000 after acquiring an additional 10,241 shares during the last quarter. US Bancorp DE increased its stake in shares of AMETEK by 41.9% during the 4th quarter. US Bancorp DE now owns 50,393 shares of the technology company’s stock worth $8,309,000 after purchasing an additional 14,882 shares during the last quarter. Orion Portfolio Solutions LLC raised its holdings in shares of AMETEK by 2.1% in the 4th quarter. Orion Portfolio Solutions LLC now owns 20,435 shares of the technology company’s stock valued at $3,308,000 after purchasing an additional 413 shares during the period. Finally, Advisory Services Network LLC lifted its stake in AMETEK by 71.3% in the 4th quarter. Advisory Services Network LLC now owns 5,391 shares of the technology company’s stock valued at $889,000 after purchasing an additional 2,244 shares during the last quarter. 87.43% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of equities analysts have weighed in on AME shares. Royal Bank of Canada lowered their price target on AMETEK from $216.00 to $215.00 and set an “outperform” rating on the stock in a research report on Friday, August 2nd. Wolfe Research upgraded AMETEK to a “hold” rating in a research note on Wednesday, September 18th. Truist Financial cut their price target on AMETEK from $204.00 to $201.00 and set a “buy” rating for the company in a report on Friday, August 2nd. TD Cowen decreased their price objective on shares of AMETEK from $165.00 to $158.00 and set a “hold” rating on the stock in a report on Monday, August 5th. Finally, Redburn Atlantic upgraded shares of AMETEK to a “strong-buy” rating in a research note on Friday, August 2nd. Five research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $186.29.
Get Our Latest Analysis on AMETEK
AMETEK Stock Down 0.3 %
AME stock opened at $170.54 on Wednesday. The company has a debt-to-equity ratio of 0.20, a current ratio of 1.26 and a quick ratio of 0.76. The stock has a market capitalization of $39.47 billion, a price-to-earnings ratio of 29.97, a PEG ratio of 2.71 and a beta of 1.17. The business’s fifty day moving average price is $166.44 and its two-hundred day moving average price is $171.12. AMETEK, Inc. has a fifty-two week low of $136.89 and a fifty-two week high of $186.32.
AMETEK (NYSE:AME – Get Free Report) last issued its earnings results on Thursday, August 1st. The technology company reported $1.66 earnings per share for the quarter, topping analysts’ consensus estimates of $1.64 by $0.02. The business had revenue of $1.73 billion during the quarter, compared to the consensus estimate of $1.78 billion. AMETEK had a return on equity of 17.41% and a net margin of 19.51%. The firm’s revenue for the quarter was up 5.4% on a year-over-year basis. During the same period in the previous year, the company posted $1.57 earnings per share. On average, equities analysts anticipate that AMETEK, Inc. will post 6.77 earnings per share for the current year.
AMETEK Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Investors of record on Monday, September 16th will be given a dividend of $0.28 per share. This represents a $1.12 dividend on an annualized basis and a dividend yield of 0.66%. The ex-dividend date of this dividend is Monday, September 16th. AMETEK’s payout ratio is 19.68%.
AMETEK Company Profile
AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company’s EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.
Further Reading
- Five stocks we like better than AMETEK
- How to Choose Top Rated Stocks
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- Dividend Payout Ratio Calculator
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Want to see what other hedge funds are holding AME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMETEK, Inc. (NYSE:AME – Free Report).
Receive News & Ratings for AMETEK Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for AMETEK and related companies with MarketBeat.com’s FREE daily email newsletter.
Source: ETF Daily News